Home » Finland » Page 5

Finland

Committee of the Whole (Thursday morning) L4. Promoting awareness-raising, education and training as part of a comprehensive approach to ensuring access to and the availability of controlled substances for medical and scientific purposes and improving their rational use

EC77/2020/L4   Belgium:There are some paras where the wording is ‘non-stigma’. A couple of paras have been agreed in informals pending on the solution of non-stigmatisation. Chair: Canada was the state proposing language on stigma Canada: If we are going to focus on PPs first we did have discussions during informals. Linking PP that references stigma …

Read more

Committee of the Whole (Wednesday afternoon) L3- Promoting and improving the collection and analysis of reliable and comparable data to strengthen balanced, integrated, comprehensive, multidisciplinary and scientific evidence-based responses to the world drug problem

-L3- Chair: Some questions have been cleared through the informals. PP6bis Chair: Agreed in CoW PP10 Chair: Agreed in CoW PP12 Netherlands: Discussion on the UN system. MS had discussion on compromise you can see below. We can agree on it here. Chair: Invite comments. We have 3 different proposals. We can accept part of …

Read more

Thematic sessions – Follow up to the 2019 Ministerial Declaration, 18 October

Third round of thematic sessions on the implementation of all international drug policy commitments following up to the 2019 Ministerial Declaration Theme addressed: ‘… synthetic opioids and the non-medical use of prescription drugs pose increasing risks to public health and safety, as well as scientific, legal and regulatory challenges, including with regard to the scheduling of substances’ Background …

Read more